Education
About Us
Working with TipRanks
Follow Us
Cardiff Oncology, Inc. (DE:XE7C)
:XE7C
Cardiff Oncology (XE7C) Ownership Overview
3.57% Insiders
4.86% Mutual Funds
22.23% Other Institutional Investors
6.45% ETFs
62.88% Public Companies and
Individual Investors
The ownership structure of Cardiff Oncology (DE:XE7C) stock is a mix of institutional, retail, and individual investors. Approximately 33.54% of the company’s stock is owned by Institutional Investors, 3.57% is owned by Insiders, and 62.88% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Dec 18, 2024 | xxxxxxxxxxxxx | $36708 | |
| Dec 16, 2024 | Renee Tannenbaum Director | xxxxxxxxxxxxx | $34200 |
| Dec 12, 2024 | Gary Pace Director | xxxxxxxxxxxxx | $940199 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $138880 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $156240 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $180978 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,444,594 | Institution | 3.68% | 10,137,731 | |
| 2,107,252 | Insider | 3.17% | 8,738,774 | |
| 1,854,892 | Institution | 2.79% | 7,692,237 | |
| 1,592,191 | Institution | 2.39% | 6,602,816 | |
| 438,247 | Institution | 0.66% | 1,817,410 | |
| 406,447 | Institution | 0.61% | 1,685,536 | |
| 218,277 | Institution | 0.33% | 905,195 | |
| 139,963 | Institution | 0.21% | 580,427 | |
| 121,293 | Institution | 0.18% | 503,002 | |
| 113,788 | Insider | 0.17% | 471,879 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,854,892 | Institution | 2.79% | 7,692,237 | |
| 438,247 | Institution | 0.66% | 1,817,410 | |
| 406,447 | Institution | 0.61% | 1,685,536 | |
| 218,277 | Institution | 0.33% | 905,195 | |
| 121,293 | Institution | 0.18% | 503,002 | |
| 53,116 | Institution | 0.08% | 220,272 | |
| 27,727 | Institution | 0.04% | 114,984 | |
| 24,797 | Institution | 0.04% | 102,833 | |
| 18,700 | Institution | 0.03% | 77,549 | |
| 15,778 | Institution | 0.02% | 65,431 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Cardiff Oncology, Inc. (DE:XE7C)?
According to the latest TipRanks data, approximately 22.23% of the company's stock is held by institutional investors, 3.57% is held by insiders, and 62.88% is held by retail investors.
What percentage of Cardiff Oncology, Inc. (DE:XE7C) stock is held by institutional investors?
According to the latest TipRanks data, approximately 22.23% of Cardiff Oncology, Inc. (DE:XE7C) stock is held by institutional investors.
What percentage of Cardiff Oncology, Inc. (DE:XE7C) stock is held by retail investors?
According to the latest TipRanks data, approximately 62.88% of Cardiff Oncology, Inc. (DE:XE7C) stock is held by retail investors.
Who owns the most shares of Cardiff Oncology, Inc. (DE:XE7C)?
Vanguard owns the most shares of Cardiff Oncology, Inc. (DE:XE7C).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.